The Wexford SciTech Venture Fund is focused on investing in early-stage companies in the industry sectors operating or seeking to operate in markets where Wexford has or is developing a Knowledge Community.
The Fund is focused on investing in early and late-stage seed opportunities. The fund will initially concentrate its efforts primarily in life sciences and technology companies. In addition to financial support, portfolio companies will have access to Wexford’s substantial network of university talent, industry experts, strategic partners, and resources to help them scale and grow.
Sector and Eligibility
The Fund is focused on companies in industry sectors operating or seeking to operate in markets where Wexford has or is developing a Knowledge Community. The Fund will seek to invest in a diverse set of companies.
Stage: The Fund typically invests in seed and early growth rounds, preferably in the form of convertible debt or SAFE, but it will consider Series A companies or later rounds that could dramatically improve the Fund’s financial return.
Target Size and Target Valuation: The Fund will typically make investments in companies of between $150,000 and $500,000 but may invest more, or less as needed. The Fund invests in companies typically with a pre-money valuation of $15 million or less.
Matching: The Fund targets a minimum 1:1 match of funding from other co-investors at the same or no better commercial terms.
Astek is a Baltimore-based medical device diagnostics company, with strong founder roots to the University of Maryland, Baltimore, that has developed an automated instrument that confirms presence of Urinary Tract Infections and simultaneously identifies best antibiotics to treat the infection considerably quicker than current clinical standards.
Previse is a Baltimore-based life science company spun out of Johns Hopkins University, with strong Founder roots the University of Maryland, Baltimore, focused on the development and commercialization of early diagnostic tests for Esophagus cancer detection and prevention.
Expert Orthopedic care from start to finish. At Commons Clinic, our top-ranked orthopedic specialists provide comprehensive minimally-invasive surgical and conservative musculoskeletal care.
President, Wexford SciTech Venture Fund
In addition to his role as President of the Wexford SciTech Venture Fund, Tom is an Executive Vice President at Wexford Science & Technology. In this role, he guides Wexford’s implementation of its Knowledge Community strategy across their development stakeholders globally to position Wexford’s research park developments as critical hubs in the regional innovation ecosystem.
Fund Manager, Wexford SciTech Venture Fund
George serve’s as Fund Manager for the Wexford SciTech Venture Fund. He is also Executive Vice President, in Evergreen Advisors’s Strategic Advisory practice. He is well-known for his successes in investing, building and managing biotech, IT, and software companies, often from the start-up stage. Prior to Evergreen he completed a 2-year tenure as Executive Director and CEO of Maryland’s Technology Development Corporation (TEDCO), the State’s Technology Transfer, Innovation Development and Venture Investing Platform.
Chairman of Advisory Committee, Wexford SciTech Venture Fund
Marco serves as Chairman of the Advisory Committee for the Wexford SciTech Venture fund and Wexford Science & Technology’s Chief Scientific Officer. In this role, he provides direction and guidance on Wexford’s Scalable Lab Platform and in helping life science companies take full advantage of the connections with universities and entrepreneurs that are at the core of our Knowledge Communities.
Chairman of Investment Committee, Wexford SciTech Venture Fund
Travis serves as Wexford SciTech Venture Fund’s Chairman of Investment Committee and Wexford Science & Technology’s Chief Community Officer. He works hand-in-hand with Wexford’s university partners, civic leaders and community groups in the Knowledge Communities we develop. His primary role is to ensure that Wexford is building inclusive communities in each of our cities and to lead the overall community engagement strategy, identify new partners and initiatives to add to the knowledge community portfolio, develop funding mechanisms to increase opportunities for under-represented innovators, and strengthen the connections between the Knowledge Community and the geography in which it resides.
Scientific Advisory Board
- Nilofer Saba Azad, M.D.
- Bob Storey
- Kyp Sirinakis
- Kristen Valdes
- Neil Davis
- Rick Kohr
Learn More about the Wexford scitech venture fund
"*" indicates required fields